Latest filings (excl ownership)
10-Q
2025 Q2
Quarterly report
30 Jan 25
8-K
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
30 Jan 25
8-K
Submission of Matters to a Vote of Security Holders
21 Nov 24
DEFA14A
Additional proxy soliciting materials
25 Oct 24
10-Q
2025 Q1
Quarterly report
24 Oct 24
8-K
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
24 Oct 24
ARS
2024 FY
Annual report to shareholders
3 Oct 24
DEFA14A
Additional proxy soliciting materials
3 Oct 24
DEF 14A
Definitive proxy
3 Oct 24
8-K
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
16 Aug 24
10-K
2024 FY
Annual report
8 Aug 24
8-K
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
1 Aug 24
SD
Conflict minerals disclosure
30 May 24
10-Q
2024 Q3
Quarterly report
25 Apr 24
8-K
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
25 Apr 24
10-Q
2024 Q2
Quarterly report
25 Jan 24
8-K
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
24 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
20 Nov 23
8-K
ResMed Adopts New Operating Model to Accelerate Long-term Growth
9 Nov 23
10-Q
2024 Q1
Quarterly report
26 Oct 23
8-K
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
26 Oct 23
DEFR14A
Revised proxy
13 Oct 23
ARS
2023 FY
Annual report to shareholders
5 Oct 23
DEFA14A
Additional proxy soliciting materials
5 Oct 23
DEF 14A
Definitive proxy
5 Oct 23
10-K
2023 FY
Annual report
10 Aug 23
8-K
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
3 Aug 23
SD
Conflict minerals disclosure
26 May 23
10-Q
2023 Q3
Quarterly report
27 Apr 23
8-K
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
27 Apr 23
8-K
Departure of Directors or Certain Officers
30 Mar 23
10-Q
2023 Q2
Quarterly report
26 Jan 23
8-K
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
26 Jan 23
8-K
Submission of Matters to a Vote of Security Holders
17 Nov 22
10-Q
2023 Q1
Quarterly report
27 Oct 22
8-K
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
27 Oct 22
DEFA14A
Additional proxy soliciting materials
5 Oct 22
DEF 14A
Definitive proxy
5 Oct 22
10-K
2022 FY
Annual report
11 Aug 22
8-K/A
Regulation FD Disclosure
11 Aug 22
Latest ownership filings
4
Brett Sandercock
11 Feb 25
4
Michael J. Farrell
11 Feb 25
144
Notice of proposed sale of securities
10 Feb 25
144
Notice of proposed sale of securities
7 Feb 25
144
Notice of proposed sale of securities
5 Feb 25
4
PETER C FARRELL
5 Feb 25
4
Michael J Rider
4 Feb 25
144
Notice of proposed sale of securities
3 Feb 25
4
Brett Sandercock
10 Jan 25
144
Notice of proposed sale of securities
8 Jan 25
4
PETER C FARRELL
3 Jan 25
4
Michael J Rider
3 Jan 25
144
Notice of proposed sale of securities
2 Jan 25
144
Notice of proposed sale of securities
2 Jan 25
4
Brett Sandercock
11 Dec 24
144
Notice of proposed sale of securities
9 Dec 24
4
PETER C FARRELL
5 Dec 24
144
Notice of proposed sale of securities
4 Dec 24
4
Michael J Rider
2 Dec 24
144
Notice of proposed sale of securities
2 Dec 24
144
Notice of proposed sale of securities
27 Nov 24
4
Michael J. Farrell
27 Nov 24
4
PETER C FARRELL
26 Nov 24
4
Justin Leong
25 Nov 24
144
Notice of proposed sale of securities
22 Nov 24
4
RONALD R TAYLOR
22 Nov 24
4
Desney Tan
22 Nov 24
4
RICHARD SULPIZIO
22 Nov 24
4
Karen Drexler
22 Nov 24
4
Witte Jan De
22 Nov 24
4
John Hernandez
22 Nov 24
4
Harjit Gill
22 Nov 24
4
Christopher DelOrefice
22 Nov 24
4
Carol Burt
22 Nov 24
4
PETER C FARRELL
22 Nov 24
4
Witte Jan De
14 Nov 24
4
PETER C FARRELL
12 Nov 24
4
Harjit Gill
12 Nov 24
4
Michael J Rider
12 Nov 24
4
Michael J. Farrell
12 Nov 24